S Schippling

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. ncbi Spotlight on anti-CD25: daclizumab in MS
    Dr Sven Schippling
    Neurologische Klinik und Poliklinik, Universitatsklinikum Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Int MS J 15:94-8. 2008
  2. ncbi Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
    Sven Jarius
    Neurocure, Charite University Medicine Berlin, Berlin, Germany
    J Neuroinflammation 9:14. 2012
  3. ncbi [Stem cell therapy in multiple sclerosis: a clinical update]
    S Schippling
    Zentrum für Molekulare Neurobiologie, Institut für Neuroimmunologie und Klinische Multiple Sklerose Forschung INIMS, Falkenried 3, 20246, Hamburg, Deutschland
    Z Rheumatol 68:214-5, 217-9. 2009
  4. ncbi Stem cell transplantation in multiple sclerosis
    Sven Schippling
    Institute of Neuroimmunology and Multiple Sclerosis Research INiMS, Center of Molecular Neurobiology, Falkenried 3, 20246 Hamburg, Germany
    J Neurol 255:43-7. 2008
  5. ncbi Quantitative T2' imaging in patients with clinically isolated syndrome
    L Y Reitz
    Department of Neurology, Institute for Neuroimmunology and Clinical Multiple Sclerosis Research inims, University Medical Center, Hamburg, DE, Germany
    Acta Neurol Scand 126:357-63. 2012
  6. ncbi Early anisotropy changes in the corpus callosum of patients with optic neuritis
    M Bester
    Department of Neuroradiology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Neuroradiology 50:549-57. 2008
  7. ncbi [Diagnosis and heterogeneity of MS in MRI]
    B Holst
    Klinik und Poliklinik für neuroradiologische Diagnostik und Intervention, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, Hamburg
    Rofo 180:112-9. 2008
  8. ncbi Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
    A Kontush
    Medical Clinic, University Hospital Eppendorf, Hamburg, Germany
    Free Radic Biol Med 30:119-28. 2001
  9. ncbi Inhibitory and facilitatory connectivity from ventral premotor to primary motor cortex in healthy humans at rest--a bifocal TMS study
    T Baumer
    Department of Neurology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Clin Neurophysiol 120:1724-31. 2009
  10. ncbi Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile?
    A Kontush
    Medizinische Klinik, Universitatskrankenhaus Eppendorf, Hamburg, Germany
    Biofactors 9:225-9. 1999

Collaborators

  • Roland Martin
  • B Holst
  • J Fiehler
  • H R Siebner
  • A Kontush
  • A Munchau
  • Christoph Heesen
  • K Fischer
  • G Koch
  • M Orth
  • T Baumer
  • L Y Reitz
  • Sven Jarius
  • M Inglese
  • N Schäffler
  • M Bester
  • Dr Sven Schippling
  • Barbara Ettrich
  • Martin Stangel
  • Peter Kern
  • Imke Metz
  • Alexander Winkelmann
  • Jörn P Sieb
  • Bernhard Hemmer
  • Christoph Munch
  • Sabine Niehaus
  • Ingo Kleiter
  • Christian Wilke
  • Hayrettin Tumani
  • Klemens Ruprecht
  • Ulf Ziemann
  • Corinna Trebst
  • Hannah Pellkofer
  • Hans P Hartung
  • Ulrich Hofstadt-van Oy
  • Uwe K Zettl U
  • Tobias Boettcher
  • Christian Zentner
  • Paulus S Rommer
  • Tania Kuempfel
  • Martin Liebetrau
  • Stefan Langel
  • Martin Marziniak
  • Marius Ringelstein
  • Kerstin Hellwig
  • Christian Geis
  • Klaus P Wandinger
  • Christian Veauthier
  • Reinhard Reuss
  • Frank Hoffmann
  • Kersten Guthke
  • Achim Berthele
  • Brigitte Wildemann
  • Florian Lauda
  • Christoph A Mayer
  • Ralf A Linker
  • Christoph Kleinschnitz
  • Johannes Brettschneider
  • Orhan Aktas
  • Jürgen H Faiss
  • J Finsterbusch
  • Florian Then Bergh
  • Arthur Melms
  • Friedemann Paul
  • Oliver Neuhaus
  • S Köpke
  • L Winkler
  • J Kroeger
  • J C Rothwell
  • S Zittel
  • G Thomalla
  • X Q Ding
  • J Hagenah
  • P P Pramstaller
  • C Gerloff
  • M Peller
  • C Klein

Detail Information

Publications13

  1. ncbi Spotlight on anti-CD25: daclizumab in MS
    Dr Sven Schippling
    Neurologische Klinik und Poliklinik, Universitatsklinikum Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Int MS J 15:94-8. 2008
    ..Safety and efficacy data from the preliminary clinical exploration as well as findings about the mechanism of action of anti-CD25 treatment are reviewed here...
  2. ncbi Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
    Sven Jarius
    Neurocure, Charite University Medicine Berlin, Berlin, Germany
    J Neuroinflammation 9:14. 2012
    ..However, little is known so far about the clinical impact of AQP4-Ab seropositivity...
  3. ncbi [Stem cell therapy in multiple sclerosis: a clinical update]
    S Schippling
    Zentrum für Molekulare Neurobiologie, Institut für Neuroimmunologie und Klinische Multiple Sklerose Forschung INIMS, Falkenried 3, 20246, Hamburg, Deutschland
    Z Rheumatol 68:214-5, 217-9. 2009
    ..Although transplant related mortality has dropped to 1%, mortality combined with concerns about long-term safety remain critical issues in a primarily non-life-threatening disease like MS...
  4. ncbi Stem cell transplantation in multiple sclerosis
    Sven Schippling
    Institute of Neuroimmunology and Multiple Sclerosis Research INiMS, Center of Molecular Neurobiology, Falkenried 3, 20246 Hamburg, Germany
    J Neurol 255:43-7. 2008
    ....
  5. ncbi Quantitative T2' imaging in patients with clinically isolated syndrome
    L Y Reitz
    Department of Neurology, Institute for Neuroimmunology and Clinical Multiple Sclerosis Research inims, University Medical Center, Hamburg, DE, Germany
    Acta Neurol Scand 126:357-63. 2012
    ..We aimed to explore the presence and extent of T2' changes in patients with a clinically isolated syndrome (CIS) and a possible association of T2' with conventional magnetic resonance imaging and clinical outcomes...
  6. ncbi Early anisotropy changes in the corpus callosum of patients with optic neuritis
    M Bester
    Department of Neuroradiology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Neuroradiology 50:549-57. 2008
    ..In this prospective study we aimed to determine whether diffusion tensor imaging (DTI) could quantify structural changes in patients with early MS...
  7. ncbi [Diagnosis and heterogeneity of MS in MRI]
    B Holst
    Klinik und Poliklinik für neuroradiologische Diagnostik und Intervention, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, Hamburg
    Rofo 180:112-9. 2008
    ..The previous challenge with respect to MRI was to support the diagnosis of MS via MRI criteria. A future problem will be the heterogeneity and classification of subgroups. This article gives an overview of both problems...
  8. ncbi Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
    A Kontush
    Medical Clinic, University Hospital Eppendorf, Hamburg, Germany
    Free Radic Biol Med 30:119-28. 2001
    ..These data suggest that Abeta(1-40) may act as a physiological antioxidant in CSF and plasma lipoproteins, functioning by chelating transition metal ions...
  9. ncbi Inhibitory and facilitatory connectivity from ventral premotor to primary motor cortex in healthy humans at rest--a bifocal TMS study
    T Baumer
    Department of Neurology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Clin Neurophysiol 120:1724-31. 2009
    ..In macaques, intracortical electrical stimulation of ventral premotor cortex (PMv) can modulate ipsilateral primary motor cortex (M1) excitability at short interstimulus intervals (ISIs)...
  10. ncbi Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile?
    A Kontush
    Medizinische Klinik, Universitatskrankenhaus Eppendorf, Hamburg, Germany
    Biofactors 9:225-9. 1999
    ..These data suggest that the level of ubiquinol-10 in human plasma may serve as a marker for liver dysfunction, reflecting its diminished reduction by the liver rather than increased consumption by oxidants...
  11. ncbi Accuracy of diagnostic tests in multiple sclerosis--a systematic review
    N Schäffler
    Institute of Neuroimmunology and Clinical MS Research, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Acta Neurol Scand 124:151-64. 2011
    ..However, the value of a very early diagnosis stays questionable as patients' benefit of new diagnostic criteria has never been addressed...
  12. ncbi T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients
    B Holst
    Department of Neuroradiology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Mult Scler 15:701-7. 2009
    ..We hypothesized that T2' imaging is feasible in routine use and reveals differences between MS patients and healthy subjects...
  13. ncbi Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study
    T Baumer
    Department of Neurology, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
    Neurology 69:1976-81. 2007
    ....